Drug Profile
Research programme: HSET allosteric inhibitors - Cancer Research Technology
Alternative Names: CW-069Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Cancer Research Technology
- Class
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Cancer in United Kingdom
- 21 Oct 2013 Early research in Cancer in United Kingdom (unspecified route)